While we were on hiatus, we received notification of our #ASCO23 abstract acceptance for discussion!!
We’re thrilled to bring more awareness of the impact #TumorBoardTuesday discussions continue to have on knowledge of novel therapies and toxicities in solid tumor oncology!
Thank you to the #MedTwitter #OncTwitter community - We couldn't have successful #TumorBoardTuesday without your support, encouragement, and engagement!
#LCSM #BCSM #GITwitter #PanCan #GU #HemOnc